+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidepressant"

Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • June 2022
  • 67 Pages
  • Global
From
Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2029

  • Report
  • March 2021
  • 120 Pages
  • Global
From
Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update

  • Report
  • December 2023
  • 117 Pages
  • Global
From
Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 292 Pages
  • Global
From
US Depression Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Depression Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Depression Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Depression Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Depression Market and Competitive Landscape - 2021 - Product Thumbnail Image

Global Depression Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Global
From
Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • November 2023
  • 231 Pages
  • Global
Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 153 Pages
  • Global
From
Depression - Pipeline Review, H2 2020 - Product Thumbnail Image

Depression - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 737 Pages
  • Global
From
Africa Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Africa Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 80 Pages
  • Africa
From
Brazil Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Brazil Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Brazil
From
China Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

China Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • China
From
France Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

France Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • France
From
Germany Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Germany Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Germany
From
India Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

India Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • India
From
Ireland Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Ireland Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Ireland
From
Japan Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Japan Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Japan
From
Russia Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Russia Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Russia
From
Saudi Arabia Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Saudi Arabia Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Saudi Arabia
From
Loading Indicator

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression. Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more